Prudential Financial Raised Gatx (GMT) Holding By $2.94 Million; 1 Analysts Bullish Mirna Therapeutics (MIRN)

June 20, 2017 - By Hazel Jackson

Among 5 analysts covering Mirna Therapeutics (NASDAQ:MIRN), 1 have Buy rating, 0 Sell and 4 Hold. Therefore 20% are positive. Mirna Therapeutics had 8 analyst reports since October 26, 2015 according to SRatingsIntel. The rating was initiated by Cantor Fitzgerald with “Buy” on Monday, October 26. The firm earned “Hold” rating on Wednesday, September 21 by Cantor Fitzgerald. The stock of Mirna Therapeutics Inc (NASDAQ:MIRN) has “Perform” rating given on Wednesday, September 21 by Oppenheimer. On Thursday, September 22 the stock rating was maintained by Citigroup with “Neutral”. The firm has “Outperform” rating given on Monday, October 26 by Oppenheimer. The firm earned “Neutral” rating on Friday, September 23 by H.C. Wainwright. On Monday, October 26 the stock rating was initiated by Leerink Swann with “Outperform”. See Mirna Therapeutics Inc (NASDAQ:MIRN) latest ratings:

Prudential Financial Inc increased Gatx Corp (GMT) stake by 55.93% reported in 2016Q4 SEC filing. Prudential Financial Inc acquired 48,220 shares as Gatx Corp (GMT)’s stock 0.00%. The Prudential Financial Inc holds 134,428 shares with $8.28M value, up from 86,208 last quarter. Gatx Corp now has $2.56 billion valuation. The stock declined 0.61% or $0.4 reaching $64.75 on the news. About shares traded. GATX Corporation (NYSE:GMT) has 0.00% since June 20, 2016 and is . It has underperformed by 16.70% the S&P500.

About shares traded. Mirna Therapeutics Inc (NASDAQ:MIRN) has declined 67.97% since June 20, 2016 and is downtrending. It has underperformed by 84.67% the S&P500.

Mirna Therapeutics, Inc. is a clinical-stage biopharmaceutical firm developing a pipeline of micro ribonucleic acid oncology therapeutics. The company has market cap of $30.45 million. The Firm is developing mimics of naturally occurring microRNAs that are designed to restore the tumor suppressor activity and aid appropriate anti-tumor immune response. It currently has negative earnings. This approach is known as microRNA replacement therapy.

Among 3 analysts covering GATX Corp (NYSE:GMT), 2 have Buy rating, 0 Sell and 1 Hold. Therefore 67% are positive. GATX Corp had 7 analyst reports since July 24, 2015 according to SRatingsIntel. The firm earned “Outperform” rating on Monday, May 9 by Wells Fargo. On Friday, January 22 the stock rating was maintained by Stifel Nicolaus with “Buy”. The stock of GATX Corporation (NYSE:GATX) has “Market Perform” rating given on Wednesday, April 20 by Avondale. The firm has “Buy” rating by Stifel Nicolaus given on Friday, July 24. Stifel Nicolaus maintained GATX Corporation (NYSE:GATX) on Friday, October 23 with “Buy” rating.

Investors sentiment increased to 1.11 in Q4 2016. Its up 0.23, from 0.88 in 2016Q3. It increased, as 18 investors sold GMT shares while 76 reduced holdings. 41 funds opened positions while 63 raised stakes. 47.39 million shares or 2.15% less from 48.44 million shares in 2016Q3 were reported. Macquarie Gp Ltd invested in 20,400 shares. Invesco Ltd owns 0% invested in GATX Corporation (NYSE:GATX) for 16,390 shares. Amalgamated Bank & Trust invested in 0.02% or 5,725 shares. Morgan Stanley invested in 0% or 206,210 shares. Deutsche Bancorporation Ag owns 78,507 shares. Pnc Service holds 6,215 shares or 0% of its portfolio. Nordea Invest Management Ab invested 0% in GATX Corporation (NYSE:GATX). Guggenheim Ltd Company invested in 58,303 shares. Royal National Bank Of Canada holds 0% or 42,238 shares in its portfolio. Aperio Gp Ltd Limited Liability Company owns 52,695 shares or 0.02% of their US portfolio. Raymond James & Associate has 5,801 shares for 0% of their portfolio. Nuveen Asset Mgmt Limited Liability Corporation reported 18,247 shares. Sta Wealth Limited owns 0.12% invested in GATX Corporation (NYSE:GATX) for 4,440 shares. Aqr Cap Management Ltd Liability Corp has 383,230 shares for 0.03% of their portfolio. Metropolitan Life Communications Ny invested 0.03% in GATX Corporation (NYSE:GATX).

Since January 23, 2017, it had 0 buys, and 12 insider sales for $1.63 million activity. On Monday, January 23 Titterton Paul F sold $188,810 worth of GATX Corporation (NYSE:GATX) or 3,140 shares. On Wednesday, June 14 Golden Deborah A sold $88,183 worth of GATX Corporation (NYSE:GATX) or 1,368 shares. Adedoyin Niyi had sold 2,403 shares worth $140,889. 638 GATX Corporation (NYSE:GATX) shares with value of $41,430 were sold by Conniff James M.. The insider Young Jeffery R. sold 230 shares worth $13,208. Brooks Michael T. also sold $390,366 worth of GATX Corporation (NYSE:GATX) on Tuesday, January 31. The insider MUCKIAN WILLIAM M sold 1,000 shares worth $59,060.

Prudential Financial Inc decreased Citigroup Inc (NYSE:C) stake by 216,830 shares to 9.48 million valued at $563.53M in 2016Q4. It also reduced Reinsurance Group Amer Inc (NYSE:RGA) stake by 66,882 shares and now owns 326,031 shares. Ally Finl Inc (NYSE:ALLY) was reduced too.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: